Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children

AIDS

Volumn 21, Issue 15, 2007, Pages 2059-2066

  Kamya, Moses R ^a,d   Gasasira, Anne F ^a   Achan, Jane ^a   Mebrahtu, Tsedal ^b   Ruel, Theodore ^b   Kekitiinwa, Adeodata ^c   Charlebois, Edwin D ^b   Rosenthal, Philip J ^b   Havlir, Diane ^b   Dorsey, Grant ^b  

^a MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MULAGO HOSPITAL   (Uganda)

^d MAKERERE UNIVERSITY   (Uganda)

Author keywords

HIV; Insecticide treated bednets; Prevention of malaria; Trimethoprim sulfamethoxazole; Uganda

Indexed keywords

AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; BIOLOGICAL MARKER; COTRIMOXAZOLE; FANSIDAR; FOLIC ACID ANTAGONIST; INSECTICIDE; SULFADOXINE;

ARTICLE; BED NET; BLOOD SMEAR; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEVER; FOLLOW UP; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INCIDENCE; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALE; PEDIATRICS; PRIORITY JOURNAL; UGANDA;

ANTIMALARIALS; BEDDING AND LINENS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT; INSECTICIDES; LONGITUDINAL STUDIES; MALARIA; MALE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; UGANDA;

EID: 34648816789     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3282ef6da1     Document Type: Article

References (23)

1. UNAIDS. UNAIDS 2006 report on the global AIDS epidemic. Geneva: UNAIDS; 2006. (http://www.unaids.org/en/HIV_data/2006GlobalReport/default.asp) [Accessed 4 August 2007].
2. USAIDS. President's Malaria Initiative. Washington, DC: USAIDS; 2005. (http://www.fightingmalaria.gov) [Accessed 4 August 2007].
3. Whitworth J, Morgan D, Quigley M, Smith A, Mayanja B, Eotu H, et al. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 2000; 356:1051-1056.
4. Francesconi P, Fabiani M, Dente MG, Lukwiya M, Okwey R, Ouma J, et al. HIV, malaria parasites, and acute febrile episodes in Ugandan adults: a case-control study. AIDS 2001; 15:2445-2450.
5. French N, Nakiyingi J, Lugada E, Watera C, Whitworth JA, Gilks CF. Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. AIDS 2001; 15:899-906.
6. Grimwade K, French N, Mbatha DD, Zungu DD, Dedicoat M, Gilks CF. Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence. Pediatr Infect Dis J 2003; 22:1057-1063.
7. Anglaret X, Chene G, Attia A, Toure S, Lafont S, Combe P, et al. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: a randomised trial. Cotrimo-CI Study Group. Lancet 1999; 353:1463-1468.
8. Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, Maurice C, et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d'Ivoire: a randomised controlled trial. Lancet 1999; 353:1469-1475.
9. Chintu C, Bhat GJ, Walker AS, Mulenga V, Sinyinza F, Lishimpi K, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet 2004; 364:1865-1871.
10. Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, Ransom R, et al. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 2004; 364:1428-1434.
11. World Health Organization. Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults in resource-limited settings: Recommendations for a public health approach. Geneva: World Health Organization; 2006. (http://www.who.int/hiv/pub/guidelines/ WHO%20CTX.pdf) [Accessed 4 August 2007].
12. Mermin J, Ekwaru JP, Liechty CA, Were W, Downing R, Ransom R, et al. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. Lancet 2006; 367:1256-1261.
13. Dorsey G, Dokomajilar C, Kiggundu M, Staedke SG, Kamya MR, Rosenthal PJ. Principal role of dihydropteroate synthase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda. Am J Trop Med Hyg 2004; 71:758-763.
14. Dorsey D, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, et al. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA 2007; 297:2210-2219.
15. Davis JC, Clark TD, Kemble SK, Talemwa N, Njama-Meya D, Staedke SG, et al. Longitudinal study of urban malaria in a cohort of Ugandan children: description of study site, census and recruitment. Malar J 2006; 5:18.
16. World Health Organization. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Geneva: World Health Organization; 2003.
17. Kyabayinze D, Cattamanchi A, Kamya MR, Rosenthal PJ, Dorsey G. Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria. Am J Trop Med Hyg 2003; 69:247-252.
18. McCollum AM, Poe AC, Hamel M, Huber C, Zhou Z, Shi YP, et al. Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J Infect Dis 2006; 194:189-197.
19. ter Kuile FO, Terlouw DJ, Kariuki SK, Phillips-Howard PA, Mirel LB, Hawley WA, et al. Impact of permethrin-treated bed nets on malaria, anemia, and growth in infants in an area of intense perennial malaria transmission in western Kenya. Am J Trop Med Hyg 2003; 68:68-77.
20. ter Kuile FO, Terlouw DJ, Phillips-Howard PA, Hawley WA, Friedman JF, Kolczak MS, et al. Impact of permethrin-treated bed nets on malaria and all-cause morbidity in young children in an area of intense perennial malaria transmission in western Kenya: cross-sectional survey. Am J Trop Med Hyg 2003; 68:100-107.
21. Kamya MR, Bakyaita NN, Talisuna AO, Were WM, Staedke SG. Increasing antimalarial drug resistance in Uganda and revision of the national drug policy. Trop Med Int Health 2002; 7:1031-1041.
22. Iyer JK, Milhous WK, Cortese JF, Kublin JG, Plowe CV. Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. Lancet 2001; 358:1066-1067.
23. Sibley CH, Hyde JE, Sims PF, Plowe CV, Kublin JG, Mberu EK, et al. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol 2001; 17:582-588.